Martingale Asset Management L P Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$110.08 - $142.92 $524,311 - $680,727
-4,763 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$99.73 - $148.48 $289,316 - $430,740
-2,901 Reduced 37.85%
4,763 $656,000
Q3 2021

Nov 12, 2021
BUY
$98.85 - $138.91 $361,395 - $507,854
3,656 Added 91.22%
7,664 $1.06 Million
Q2 2021

Aug 13, 2021
BUY
$65.78 - $105.02 $263,646 - $420,920
4,008 New
4,008 $389,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email